| abstract |
The present invention relates to the use, for affinity purification of a protein, of a compound according to the general formula (I), wherein A is selected f The present invention relates to compounds according to the general formula (I), and to their use for affinity purification of a protein. Preferably, the entity to be separated or purified is an antibody, in particular an antibody of the Bevacizumab type or the Ranibizumab type. |